Live
- Pioneering machine learning and GIS in agri-food systems
- Aha OTT Launches Writers Talent Hunt to Empower New Voices in Telugu Cinema
- Chhath festivities turn sour for two families in Bihar
- Preparations afoot for evening Arghya in Patna
- Vanara Celluloid announces debut project ‘Tribanadhari Barbarik’
- IPL player auction: James Anderson hopes IPL would help him in his coaching career
- ‘Jithender Reddy’ team expresses confidence on film’s content
- TN farmers plan major stir against Land Consolidation Act, 2023
- Rahul, Priyanka and Kharge to campaign for MVA in Maharashtra next week
- Indiranagar welcomes a new culinary landmark: Rameshwaram cafe expands with fresh flavors and spacious dining
Serum working on vaccine for Mpox
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a...
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a year's time. The World Health Organisation on August 14 declared the Mpox outbreak a public health emergency of international concern.
The move came after a sudden increase in cases was recorded in parts of Africa.
In India, around 30 Mpox cases have been detected since 2022. The most recent case in the country was reported in March 2024.
"In view of the global health emergency declared due to Mpox outbreak, Serum Institute of India is currently working on developing a vaccine for this disease to cater to millions of lives that might be at risk," Serum Institute of India CEO Adar Poonawalla said in a statement.
Hopefully, with the ongoing progress, the Pune-based vaccine major will have more updates and positive news to share within a year's time, he added.
